A Complete Procurement & Compliance Blueprint for Pharmaceutical Logistics Partners

In pharmaceutical logistics, winning a contract is not about being the cheapest option — it is about being the most compliant, reliable, and audit-ready partner.

For global pharma companies, selecting a logistics provider is a structured procurement process driven by RFP (Request for Proposal) documents. These documents are not simple questionnaires — they are detailed evaluation frameworks that determine whether a logistics company is qualified to handle life-saving medicines, vaccines, biologics, and clinical trial materials.

This guide explains exactly what global pharmaceutical companies include in RFPs, how they evaluate vendors, and what logistics providers like Arib Shipping must demonstrate to win high-value healthcare logistics contracts.

---

1. What is an RFP in Pharmaceutical Logistics?

An RFP (Request for Proposal) is a formal procurement document issued by pharmaceutical companies when they need to select a logistics partner.

Unlike general freight procurement, pharma RFPs focus heavily on:

• Regulatory compliance (GDP, WHO, FDA standards)
• Cold chain integrity
• Risk management systems
• Technology and tracking visibility
• Audit readiness and documentation control

In simple terms:
👉 An RFP decides whether a logistics company is “qualified enough to handle patient-critical shipments.”

---

2. Core Sections in a Pharma Logistics RFP

2.1 Company Profile & Operational Capability

Pharma companies first evaluate whether the logistics provider is structurally capable.

They typically request:

• Company registration and legal structure
• Global operational footprint
• Warehousing and cold storage capacity
• Fleet and transportation capabilities
• Experience in pharmaceutical logistics

👉 This section answers one question:
“Can you actually handle healthcare logistics at scale?”

---

2.2 Regulatory Compliance Documentation

This is the most critical section of any pharma RFP.

Companies require proof of compliance with:

• GDP (Good Distribution Practice)
• WHO guidelines
• FDA requirements (for US-bound shipments)
• Local regulatory authorities (UAE MOHAP, EU GDP, etc.)

They also require:

• Audit history and certifications
• Standard Operating Procedures (SOPs)
• Deviation and corrective action systems (CAPA)
• Staff training records

👉 Non-compliance here leads to immediate disqualification.

---

2.3 Cold Chain Management Capabilities

Pharmaceutical products require strict temperature control. RFPs evaluate:

• Temperature range capability (2°C–8°C, -20°C, -70°C)
• Passive and active packaging systems
• Refrigerated transport infrastructure
• Real-time temperature monitoring systems
• Backup systems during failure scenarios

Even a minor excursion can result in product rejection or patient risk, making this section highly critical.

---

2.4 Technology & Supply Chain Visibility

Modern pharma RFPs heavily prioritize digital capability.

Companies expect:

• Real-time GPS shipment tracking
• IoT temperature sensors
• Automated alerts for temperature excursions
• Dashboard-based visibility systems
• API integration with client systems

👉 Visibility is no longer optional — it is a compliance requirement.

---

2.5 Risk Management Framework

Pharma companies evaluate how logistics providers respond to disruptions.

They request:

• Risk assessment methodology
• Contingency routing plans
• Emergency response protocols
• Redundant warehousing or transport options
• Historical incident handling examples

👉 This section determines operational reliability under stress conditions.

---

2.6 Quality Assurance & Audit Readiness

Logistics partners must demonstrate continuous audit readiness.

Key expectations include:

• Internal audit systems
• Regulatory inspection readiness
• Deviation reporting systems
• Traceability from origin to delivery
• Documentation accuracy and retention policies

Pharma companies often simulate audits during vendor evaluation.

---

2.7 Service Level Agreements (SLA Requirements)

RFPs define strict performance expectations such as:

• On-time delivery rates (typically >95%)
• Temperature compliance rates
• Response time to incidents
• Reporting frequency
• Claims handling timelines

Failure to meet SLA benchmarks often leads to contract termination.

---

3. How Pharma Companies Evaluate RFP Responses

After submission, companies score vendors based on:

• Compliance strength (highest weightage)
• Operational capacity
• Technology capability
• Cost efficiency
• Risk mitigation readiness
• Previous industry experience

👉 Importantly, lowest cost rarely wins in pharma logistics procurement.

---

4. Why RFPs Are Becoming More Complex in 2026

Pharma logistics RFPs have evolved significantly due to:

• Growth of biologics and temperature-sensitive drugs
• Increased global regulatory enforcement
• Demand for real-time shipment transparency
• Rising supply chain disruptions
• Expansion of global clinical trials

Today’s RFPs are not just procurement tools — they are risk governance documents.

---

5. How Logistics Providers Like Arib Shipping Win RFPs

To succeed in competitive pharma logistics procurement, providers must demonstrate:

• GDP-compliant infrastructure
• End-to-end cold chain reliability
• Real-time digital visibility systems
• Proven handling of clinical and pharmaceutical shipments
• Strong regional and global network coverage
• Audit-ready operational documentation

At Arib Shipping, compliance, precision, and transparency are embedded into every shipment — ensuring alignment with global pharmaceutical procurement standards.

Pharmaceutical RFPs are no longer simple vendor selection tools — they are rigorous compliance and risk evaluation systems designed to protect patient safety and product integrity.

For logistics providers, success depends on more than operational strength. It requires documented compliance, technological maturity, and proven cold chain reliability.

Companies that understand and align with these expectations are the ones that secure long-term pharmaceutical logistics partnerships.